Andrew D. RuskinPartnerK&L Gates LLPWebsitewww.klgates.comOrganization ProfileFull ProfileConnectEmailTwitterLinkedIn202-778-9415 Professional Biography Andrew Ruskin is a partner in the firm’s Washington, D.C. office. He is a member of the health care and FDA practice group. Areas of Focus Health Care and FDA Food, Drugs, Medical Devices, and Cosmetics (FDA) More Legal and Business Bylines From Andrew D. Ruskin OIG Finalizes Rebate Rules: Removal of Safe Harbor Protections for Rebates and Creation of New Safe Harbors for Other Discounts and Service Fees - (Posted On Wednesday, December 02, 2020) 340B Update: Ryan White Clinics Sue in Response to Contract Pharmacy Actions as Congress Requests Information on Ways to Improve the 340B Program - (Posted On Friday, October 16, 2020) CMS'S Proposed Phase-Out of the Inpatient Only List is not Entirely Welcome News - (Posted On Tuesday, September 29, 2020) 340B UPDATE: Congress and the Administration Respond to Drug Manufacturers' 340B Contract Pharmacy Actions - (Posted On Saturday, September 26, 2020) 340B Update: Appellate Court Upholds 340B Payment Reduction as CMS Proposes Further Reductions for 2021 [Podcast] - (Posted On Thursday, August 13, 2020) 340B Update: Appeals Court Upholds 340B Payment Reduction Under the OPPS as CMS Proposes Further Reductions for CY 2021 - (Posted On Friday, August 07, 2020) Appellate Court's Reversal in AHA v. Azar Poses Existential Threat to Medicare Outpatient Prospective Payment System - (Posted On Thursday, July 30, 2020) President Trump Signs Drug Pricing Executive Orders Reinforcing the Administration's Priorities - (Posted On Monday, July 27, 2020) K&L Gates Triage: Recent Developments in the 340B Drug Pricing Program [Podcast] - (Posted On Thursday, July 23, 2020) 340b Update: HRSA Indicates It Lacks Authority to Enforce 340b Program Guidance - (Posted On Tuesday, July 21, 2020) Pagination Previous page ‹ Previous Page 3 Current Legal Analysis The Top 5 USERRA Traps and How to Avoid Them [Podcast] by: Amy Quick Glenos , James A. Patton Cross-Border Catch-Up- Cultural and Legal Considerations in Global Investigations, Part 3 [Podcast] by: Patty Shapiro , Kaitlin M. Thompson What Employers Need to Know About the End of Haiti’s TPS Protections by: Justin T. Hill Everlight Electronics’ $5.15M FCA Settlement by: Tycko & Zavareei Whistleblower Practice Group Keyword Bidding Alone Doesn’t Constitute Trademark Infringement by: Jolie B. Schenerman BIS Investigations: A Comprehensive Guide to Export Control Enforcement and Defense by: Diana Friling FinCEN Finalizes Corporate Transparency Act Rollback by: A.J. S. Dhaliwal , Mehul N. Madia States Sue OCC Over Escrow Interest Preemption Rules by: A.J. S. Dhaliwal , Mehul N. Madia NYDFS Secures $250,000 Cybersecurity Settlement with Money Transmitter by: A.J. S. Dhaliwal , Mehul N. Madia CFTC Exercises Emergency Authority Amid New York Prediction Market Dispute by: A.J. S. Dhaliwal , Mehul N. Madia Wound Care Under the Microscope: DOJ’s Data-Driven National Takedown Targets Fraudulent Reimbursements and Kickback Schemes by: Danielle H. Tangorre , Seth B. Orkand DOJ’s 2026 Health Care Fraud Takedown Signals Medicaid Enforcement Priorities by: Danielle H. Tangorre , Seth B. Orkand Privacy Tip #503 – Read This Before You Upload Medical Information into an AI Tool by: Linn F. Freedman CCPA Cybersecurity Audits Are Coming: What Companies Should Do Now by: Kathryn M. Rattigan Data Brokers Beware: California Settlement Highlights Risks in High-Friction Opt-Out Processes by: Kathryn M. Rattigan Upcoming Events Sep 14-16 2026 Private Wealth Management Summit by Marcus Evans Sep 17-18 2026 Chief Litigation Officer Summit by Marcus Evans Sep 17-18 2026 IP Law Summit by Marcus Evans Oct 19-20 2026 European Corporate Counsel Summit by Marcus Evans Print
